• "Hair is your crown and glory" - Black women's experiences of living with alopecia and the role of social support
• A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
• A rare case of alopecia universalis
• A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
• A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis
• Allergen desensitization reduces the severity of relapsed alopecia areata in dust-mite allergic patients
• Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis?
• Alopecia Totalis
• Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report
• Alopecia Universalis in an Elderly Chinese Man Induced by Sacubitril/Alisartan, a Novel Angiotensin Receptor-Neprilysin Inhibitor
• Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
• Assessing Patient's Values When Selecting Treatments for Alopecia Areata: A Cross-Sectional Survey Study
• Autoimmune, Inflammatory, Atopic, Thyroid, and Psychiatric Outcomes of Offspring Born to Mothers With Alopecia Areata
• C-reactive protein as a novel biomarker for vitamin D deficiency in alopecia areata
• Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
• Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
• Commonly Associated Disorders with Complete Scalp Alopecia in Early Childhood: A Review
• Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial
• Diphenylcyclopropenone alleviates trachyonychia in alopecia universalis
• Effective management Alopecia totalis by Ayurveda - A case report
• Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis
• Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
• Emergence of Janus kinase inhibitors led to increase in proportion of severe alopecia areata patients receiving treatment: A retrospective cohort study
• European expert consensus statement on the systemic treatment of alopecia areata
• Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
• Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
• Intralesional Pentoxifylline Injection Versus Triamcinolone Acetonide in Treating localized Alopecia Areata: A Comparative Study
• Janus kinase inhibitors for alopecia areata
• Modified Mediterranean Diet With Anti-Inflammatory Features and Oral Butyrate Supplementation Appears to Have No Effect in Cases of Alopecia Areata Universalis and Totalis: Experience With 20 Patients
• Modified Mediterranean Diet With Anti-Inflammatory Features and Oral Butyrate Supplementation Appears to Have No Effect in Cases of Alopecia Areata Universalis and Totalis: Experience With 20 Patients
• Overall and demographic subgroup incidences of alopecia areata, alopecia totalis, and alopecia universalis in the United States
• Post-Traumatic Stress Disorder in Patients with Alopecia Areata: A Survey Study in the USA
• Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
• Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
• Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
• Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
• Successful treatment of alopecia universalis with abrocitinib: a case report
• Successful treatment of concomitant alopecia universalis and Crohn's disease with upadacitinib: A case report
• Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
• Survey of pediatric dermatologist views on treatment for alopecia areata
• Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
• The Association between Number of Follicular Stelae and Severity and Treatment Response of Alopecia Areata Cases: A Retrospective Study
• The Association between the Number of Follicular Stelae and Severity and Treatment Response of Alopecia Areata Cases: A Retrospective Study
• The Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata: A Review Article
• The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995-2016
• The frequency of fatty liver in patients with alopecia areata: A case-control study
• The Gut and Skin Microbiome in Alopecia: Associations and Interventions
• Tofacitinib in Pediatric Alopecia Areata Totalis and Alopecia Universalis: A Retrospective Analysis From India
• Tofacitinib in the Management of Alopecia Universalis
• Treatment of Alopecia Universalis in a Child with Down Syndrome
• Treatment Patterns for Alopecia Areata in the US
• Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis
• Treatments for alopecia areata: a network meta-analysis
• Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
• Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review